
Managing Postpartum Psychosis Through Lithium-Based Treatment, Screening, and Team-Based Care
Host Megan Maroney and guest Mei T. Liu discuss postpartum psychosis as an obstetric and psychiatric emergency closely tied to bipolar disorder, covering risk factors, screening, and lithium-based treatment.
In this episode of Psychiatric Pharmacy Pulse, host Megan Maroney, PharmD, BCPP, FAAPP, and guest Mei T. Liu, PharmD, BCPP, both of whom are clinical associate professors at the Ernest Mario School of Pharmacy, look at postpartum psychosis. It is somewhat rare, occurring in about 1 to 2 per 1000 births, but it is an obstetric and psychiatric emergency that should be treated in the inpatient setting. Symptoms usually begin 3 to 10 days after delivery and can include hallucinations, delusions, rapid mood swings, and thoughts of harming oneself or the infant. Bipolar disorder is among the strongest predictors. Up to almost 1 in 5 deliveries in women with bipolar disorder result in postpartum psychosis, and about half of patients go on to be diagnosed with bipolar disorder or another psychiatric condition. Family history, previous episodes, and sleep disturbances also raise risk, although about one-third of patients have no psychiatric history.
There is no universal screening recommendation for postpartum psychosis. Still, the American College of Obstetricians and Gynecologists (ACOG) recommends that all patients receiving prenatal and postpartum care be screened for bipolar disorder with a validated tool before treatment for depression or anxiety starts. The hosts point to the brief, scripted Composite International Diagnostic Interview bipolar screen and to ACOG’s standardized suicide risk screener as practical tools for clinicians outside psychiatry. They also explain how to tell common intrusive, anxiety-driven thoughts apart from high-risk thoughts of harming the infant. In the high-risk case, the thoughts feel comforting or justified to the patient and come with a lack of insight.
On treatment, Maroney and Liu describe a staged approach. A benzodiazepine comes first, an antipsychotic is added if needed, and lithium follows. Most patients respond to lithium, which ACOG also considers the gold standard for preventing future episodes. They suggest about 9 months of maintenance therapy followed by an individualized reassessment. They also discuss breastfeeding: lithium requires infant monitoring and pediatrician involvement, lamotrigine is a concern because of high passage into breast milk, and electroconvulsive therapy is an option. They advise avoiding antidepressants when possible because of the risk of switching into mania.
The episode closes with resources, including the National Maternal Mental Health Hotline (1-833-TLC-MAMA) and the peer support group Action on Postpartum Psychosis.
REFERENCES
Newmark RL, Bogen DL, Wisner KL, Isaac M, Ciolino JD, Clark CT. Risk-Benefit assessment of infant exposure to lithium through breast milk: a systematic review of the literature. International Review of Psychiatry. 2019;31(3):295–304. doi:10.1080/09540261.2019.1586657
Bergink V, Akbarian S, Byatt N, et al. Postpartum Psychosis and Bipolar Disorder: Review of Neurobiology and Expert Consensus Statement on Classification. Biol Psychiatry. 2026;99(9):740-747. doi:10.1016/j.biopsych.2025.10.016
Bergink V, Burgerhout KM, Koorengevel KM, et al. Treatment of psychosis and mania in the postpartum period. American Journal of Psychiatry. 2015;172(2):115-123. doi:10.1176/appi.ajp.2014.13121652
ACOG Committee on Clinical Practice Guidelines-Obstetrics. Screening and Diagnosis of Mental Health Conditions During Pregnancy and Postpartum: ACOG Clinical Practice Guideline No. 4. Obstet Gynecol. 2023;141(6):1232-1261. doi:10.1097/AOG.0000000000005200
ACOG Committee on Clinical Practice Guidelines-Obstetrics. Treatment and Management of Mental Health Conditions During Pregnancy and Postpartum: ACOG Clinical Practice Guideline No. 5. Obstet Gynecol. 2023;141(6):1262-1288. doi:10.1097/AOG.0000000000005202
Wisner KL, Murphy C, Thomas MM. Prioritizing Maternal Mental Health in Addressing Morbidity and Mortality. JAMA Psychiatry. 2024;81(5):521-526. doi:10.1001/jamapsychiatry.2023.5648
Almeida M. The Maternal Mental Health Crisis-A Dangerous Blind Spot in US Medicine. JAMA. 2026;336(15):1303-1304. doi:10.1001/jama.2026.20213
Friedman SH, Reed E, Ross NE. Postpartum Psychosis. Curr Psychiatry Rep. 2023;25(2):65-72. doi:10.1007/s11920-022-01406-4
To provide feedback or suggest topics of discussion for Psychiatric Pharmacy Pulse, please reach out to Gillian McGovern, Editor (
Related to this article








